Score Overview
Explore the 2021 public Archive ranking β
Where Innoviva Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- INVA
2015: 89.7% Β· 2021: 27.3% Β· free through 2021 Β· longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 21.23 | β |
1 Year2025-09-26 | $ 18.86 | 12.57% |
5 Years2021-09-28 | $ 17.20 | 23.43% |
10 Years2016-09-28 | $ 11.21 | 89.38% |
20 Years2006-09-28 | $ 20.00 | 6.13% |
All Time2004-10-05 | $ 13.55 | 56.71% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | All Time2004-10-05 |
|---|---|---|---|---|---|---|
| Price | $ 21.23 | $ 18.86 | $ 17.20 | $ 11.21 | $ 20.00 | $ 13.55 |
| Return | β | 12.57% | 23.43% | 89.38% | 6.13% | 56.71% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 443M | $ 357M | $ 570M |
| 2025 | $ 425M | $ 271M | $ 550M |
| 2024 | $ 358M | $ 23M | $ 412M |
| 2023 | $ 310M | $ 179M | $ 193M |
| 2022 | $ 331M | $ 213M | $ 291M |
| 2021 | $ 391M | $ 265M | $ 201M |
| 2020 | $ 336M | $ 224M | $ 246M |
| 2019 | $ 261M | $ 157M | $ 350M |
| 2018 | $ 261M | $ 395M | $ 114M |
| 2017 | $ 217M | $ 134M | $ 129M |
| 2016 | $ 133M | $ 59M | $ 150M |
| 2015 | $ 53M | -$ 18M | $ 187M |
| 2014 | $ 8M | -$ 168M | $ 240M |
| 2013 | $ 4M | -$ 170M | $ 465M |
| 2012 | $ 5M | -$ 18M | $ 248M |
| 2011 | $ 24M | -$ 115M | $ 240M |
| 2010 | $ 24M | -$ 83M | $ 309M |
| 2009 | $ 24M | -$ 85M | $ 155M |
| 2008 | $ 23M | -$ 93M | $ 200M |
| 2007 | $ 22M | -$ 159M | $ 126M |
| 2006 | $ 19M | -$ 166M | $ 201M |
| 2005 | $ 12M | -$ 143M | $ 161M |
| IPO2004 | $ 8M | -$ 102M | $ 257M |

Innoviva Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 53M to $ 425M and net income went from -$ 18M to $ 271M. Revenue increased in 8 of those 10 years; net income in 6.
Between 2005 and 2025, revenue grew from $ 12M to $ 425M and net income went from -$ 143M to $ 271M. Revenue increased in 15 of those 20 years; net income in 14.
Innoviva Inc currently holds a 20-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.
Membership
Continue INVAβs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Neogen CorporationNEOGΒ· revenue grew in 90% of years
Omnicell IncOMCLΒ· revenue grew in 80% of years
Fresenius Medical Care CorporationFMSΒ· revenue grew in 80% of years
Ligand Pharmaceuticals IncorporatedLGNDΒ· revenue grew in 75% of years
Bristol-Myers Squibb CompanyBMYΒ· revenue grew in 65% of years